Aspen Neuroscience: Funding, Investors & Team (Sep 2026)
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs.
Aspen Neuroscience has raised $381M across 5 funding rounds on record, the most recent a Series C of $115M announced in Nov 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aspen Neuroscience Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Aspen Neuroscience Funding Rounds
Aspen Neuroscience raised $70.0M in an undisclosed round announced in Apr 2020.
2.1 years later, a Series B of $148M was announced in May 2022.
7 months later, an undisclosed round of $40.0M was announced in Dec 2022.
1.4 years later, an undisclosed round of $8.0M was announced in May 2024.
1.5 years later, a Series C of $115M was announced in Nov 2025.
Aspen Neuroscience Founders and Leadership Team
Contact details for the Aspen Neuroscience team: 1 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Aspen Neuroscience Funding Compared to Other Biotechnology Startups
Aspen Neuroscience's latest round of $115M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aspen Neuroscience in Biotechnology and San Diego
Companies Similar to Aspen Neuroscience
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Aspen Neuroscience Funding FAQs
What does Aspen Neuroscience do?
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs.
How much funding has Aspen Neuroscience raised?
Aspen Neuroscience has raised $381M across 5 rounds on record. The most recent is a Series C of $115M announced in Nov 2025.
When did Aspen Neuroscience last raise funding?
Aspen Neuroscience's most recent funding round on record is a Series C of $115M, announced in Nov 2025.
Who founded Aspen Neuroscience?
FundedIQ lists Jeanne Loring (Founder) at Aspen Neuroscience.
Who is the CEO of Aspen Neuroscience?
Howard Federoff is listed as CEO at Aspen Neuroscience.
Where is Aspen Neuroscience headquartered?
Aspen Neuroscience is based in San Diego, California, United States.
How many employees does Aspen Neuroscience have?
Aspen Neuroscience is in the 51-100 employee band.
How does Aspen Neuroscience's funding compare to other Biotechnology startups?
Aspen Neuroscience's latest round of $115M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Aspen Neuroscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aspen Neuroscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.